| Serial Number | 98686425 |
| Word Mark | HIPSCORE |
| Filing Date | Wednesday, August 7, 2024 |
| Status | 692 - WITHDRAWN BEFORE PUBLICATION |
| Status Date | Tuesday, September 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Tissues for surgical use being surgical implants comprised of living tissues based on human induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use using human-induced pluripotent stem cells |
| Pseudo Mark | HIP SCORE |
| Goods and Services | Scientific and technological services;, namely, scientific research, analysis, testing, and evaluation in the field of human-induced pluripotent stem cells; Scientific and technological services, namely, testing in the field of human-induced pluripotent stem cells; authentication in the field of human-induced pluripotent stem cells; quality control for others in the field of human-induced pluripotent stem cells |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 7, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 7, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | IUF Leibniz-Institut für umweltmedizinische Forschung GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Düsseldorf 40225 DE |
| Event Date | Event Description |
| Wednesday, August 7, 2024 | NEW APPLICATION ENTERED |
| Wednesday, January 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 12, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 13, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, February 13, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, May 12, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, February 13, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 12, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, August 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 26, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 26, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 26, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 26, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 26, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 16, 2025 | WITHDRAWN FROM PUB - OG REVIEW QUERY |